Consonance Capital

Latest statistics and disclosures from Consonance Capital Management's latest quarterly 13F-HR filing:

Companies in the Consonance Capital Management portfolio as of September 2019 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Amarin Corporation (AMRN) 9.59 6.39M -41% 15.16
Catalyst Pharmaceutical Partners (CPRX) 9.39 17.88M 5.31
United Therapeutics Corporation (UTHR) 7.64 967569 -21% 79.75
Globus Med Inc cl a 6.64 1.31M NEW 51.12
Tandem Diabetes Care Inc 5.97 1.02M NEW 58.98
Karyopharm Therapeutics 5.56 5.84M +13% 9.62
Uniqure Nv shs 5.56 1.43M -28% 39.36
Vericel 5.46 3.64M -15% 15.14
Align Technology (ALGN) 5.35 299000 NEW 180.92
Omeros Corporation (OMER) 4.57 2.83M +33% 16.33
Epizyme 4.06 3.98M +14% 10.32
Oxford Immunotec Global 3.53 2.14M -17% 16.63
STAAR Surgical Company (STAA) 3.13 1.23M NEW 25.78
Iovance Biotherapeutics 3.02 1.68M +47% 18.20
ArQule (ARQL) 2.85 4.01M NEW 7.17
Kadmon Hldgs Inc Com stock 2.67 10.69M -8% 2.52
Retrophin 2.65 2.31M -42% 11.59
Insulet Corporation (PODD) 2.54 155800 NEW 164.93
Adma Biologics 2.25 5.11M +11% 4.45
Caredx 1.62 726128 NEW 22.61
Aurinia Pharmaceuticals 1.35 2.56M -39% 5.34
Chemocentryx 1.12 1.67M 6.78
Biosante Pharmaceuticals 1.03 142943 72.88
Mustang Bio Inc 1.02 3.16M NEW 3.26
Krystal Biotech Inc 0.77 224090 NEW 34.73
Savara 0.41 1.57M -49% 2.65
Sarepta Therapeutics 0.09 12000 NEW 75.33
Homology Medicines Inc 0.07 40557 NEW 18.10
Immunomedics (IMMU) 0.06 45000 -68% 13.27
Intra Cellular Therapies 0.01 20000 NEW 7.45

Past 13F-HR SEC Filings by Consonance Capital Management

View All Filings